Incannex Healthcare partners with Monash University to develop virtual reality psychedelic treatment for anxiety disorders

Clinical-stage medicinal cannabis and psychedelic pharmaceutical company Incannex Healthcare (ASX: IHL) has secured a licence agreement with Victoria’s Monash University to develop a novel treatment for anxiety which combines virtual reality and psychedelic medicines.

Related Keywords

Australia ,Monash ,South Australia ,Joel Latham ,Paul Liknaitzky ,Murat Yu ,Turner Institute For Brain ,Victoria Monash University ,Mental Health ,Turner Institute ,Incannex Healthcare ,Monash University ,